RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:SAMSN1 restrains NK cell mediated anti-tumor immunity in hepatocellular carcinoma.
SAMSN1 restrains NK cell mediated anti-tumor immunity in hepatocellular carcinoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
NK细胞是抗肿瘤免疫的关键介质,其功能在肿瘤微环境中常受到损害。在此,我们确定SAM结构域、SH3结构域和核定位信号1(SAMSN1)为一个此前未被识别的免疫检查点,在肝细胞癌(HCC)中主要调控NK细胞功能。单细胞RNA测序(scRNA-seq)分析显示,HCC患者瘤内NK细胞中SAMSN1显著上调,与颗粒酶B表达降低和预后不良相关。在原位Hepa1-6肝细胞癌模型中,全身性Samsn1敲除(Samsn1 -/-)小鼠表现出34%的肿瘤负荷减少,同时NK细胞颗粒酶B产生增强(P = 0.0002)。关键的是,仅NK细胞特异性缺失(Samsn1 f/f -Ncr1 Cre+)即可重现这一治疗效果(41%的肿瘤负荷减少,P = 0.0017),表明SAMSN1主要通过对瘤内NK细胞而非HCC微环境中其他免疫细胞群发挥作用。在机制上,SAMSN1抑制NK细胞活化、增殖和颗粒酶B产生。这些发现表明SAMSN1是一个可靶向的NK细胞检查点,对HCC免疫治疗具有直接的治疗意义。
NK cells are critical mediators of anti-tumor immunity whose function is frequently compromised in the tumor microenvironment.
Here we identify SAM domain, SH3 domain and nuclear localization signals 1 (SAMSN1) as a previously unrecognized immune checkpoint that predominantly regulates NK cell function in hepatocellular carcinoma (HCC). Single-cell RNA sequencing (scRNA-seq) analysis reveals significant SAMSN1 upregulation in intratumoral NK cells from HCC patients, correlating with reduced granzyme B expression and poor prognosis.
In orthotopic Hepa1-6 hepatocellular carcinoma models, global Samsn1 knockout (Samsn1 -/- ) mice exhibits 34% tumor burden reduction with enhanced NK cell granzyme B production (P = 0. 0002). Critically, NK cell-specific deletion alone (Samsn1 f/f -Ncr1 Cre+ ) recapitulates this therapeutic effect (41% tumor burden reduction, P = 0. 0017), demonstrating that SAMSN1 functions predominantly through intratumoral NK cells rather than other immune populations in the HCC microenvironment.
Mechanistically, SAMSN1 suppresses NK cell activation, proliferation, and granzyme B production.
These findings indicate SAMSN1 as a targetable NK cell checkpoint with direct therapeutic implications for HCC immunotherapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。